Champions Oncology (CSBR) Net Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -113.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 220.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -413.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -515.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 5,083.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -7,766.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 53.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.07 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -752,733.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 53.00 |
| Apr 30, 2026 | 1,003.00 |
| Jan 31, 2026 | -2,807.00 |
| Oct 31, 2025 | -382.00 |
| Jul 31, 2025 | -1,267.00 |
| Apr 30, 2025 | -1,407.00 |
| Jan 31, 2025 | 4,743.00 |
| Oct 31, 2024 | 2,329.00 |
| Jul 31, 2024 | 2,977.00 |
| Apr 30, 2024 | 1,881.00 |
| Jan 31, 2024 | -196.00 |
| Oct 31, 2023 | -1,778.00 |
| Jul 31, 2023 | -1,811.00 |
| Apr 30, 2023 | -1,692.00 |
| Jan 31, 2023 | -2,506.00 |
| Oct 31, 2022 | -246.00 |
| Jul 31, 2022 | -79.00 |
| Apr 30, 2022 | 370.00 |
| Jan 31, 2022 | -290.00 |
| Oct 31, 2021 | 234.00 |